• /

群馬大学 生体調節研究所

アクセス アクセス
  • HOME
  • Diagnostic Radiology and Nuclear Medicine (Yoshito Tsushima)

Publications

Diagnostic Radiology and Nuclear Medicine (Yoshito Tsushima)

No. Year Title Author Corresponding Journal Vol. Pages
1 2013 Peroxisome proliferator‐activated receptor‐γ in capillary endothelia promotesfatty acid uptake by heart during long‐term fasting. Goto K, Iso T, Hanaoka H, Yamaguchi A, Suga T, Hattori A, Irie Y, Shinagawa Y, Matsui H, Syamsunarno MR, Matsui M, Haque A, Arai M, Kunimoto F, Yokoyama T, Endo K, Gonzalez FJ, Kurabayashi M Iso T J Am Heart Assoc 18 e004861
2 2013 Perfusion evaluation of lung cancer: assessment using dual-input perfusion computed tomography. Nakano S, Gibo J, Fukushima Y, Kaira K, Sunaga N, Taketomi-Takahashi A, Tsushima Y, Mori M Nakano S J Thoracic Imaging 28 253-262
3 2013 Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography. Ohshima Y, Hanaoka H, Tominaga H, Kanai Y, Kaira K, Yamaguchi A, Nagamori S, Oriuchi N,Tsushima Y, Endo K, Ishioka NS Kaira K Ann Nucl Med 27 314-324
4 2013 2-[¹⁸F]fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography (PET) findings of chronic expanding intrapericardial hematoma: a potential interpretive pitfall that mimics a malignant tumor. Tokue H, Tokue A, Okauchi K, Tsushima Y Tokue H J Cardiovascular Surg 8 13
5 2013 Diagnostic usefulness of transporter 1 (LAT1) expression in oral squamous cell carcinoma18F-FAMT PET and L-type amino acid. Nobusawa A, Kim M, Kaira K, Miyashita G, Negishi A, Oriuchi N, Higuchi T, Tsushima Y, Kanai Y, Yokoo S, Oyama T Kaira K Eur J Nucl Med Mol I 40 1692-1700
6 2013 Complementary roles of tumor specific PET tracer 18F-FAMT to 18F-FDG PET|CT for the assessment of bone metastasis. Morita M, Higuchi T, Achmad A, Tokue A, Arisaka Y, Tsushima Y Morita M Eur J Nucl Med Mol I 40 1672-1681
7 2013 Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model. Nakajima T, Sano K, Choyke PL, Kobayashi H Nakajima T Theranostics 3 357-365
8 2013 Capillary endothelial Fatty Acid binding proteins 4 and 5 play a critical role in Fatty Acid uptake in heart and skeletal muscle. Iso T, Maeda K, Hanaoka H, Suga T, Goto K, Syamsunarno MR, Hishiki T, Nagahata Y, Matsui H, Arai M, Yamaguchi A, Abumrad NA, Sano M, Suematsu M, Endo K, Hotamisligil GS, Kurabayashi M Iso T Arterioscler Thromb Vasc Biol 33 2549-2557
9 2013 A critical role of fatty acid binding protein 4 and 5 (FABP4|5) in the systemic response to fasting Syamsunarno MA, Iso T, Hanaoka Y, Yamaguchi A, Obokata M, Koitabashi N, Goto K, Hishiki T, Nagahata Y, Matsui H, Sano M, Kobayashi M, Kikuchi O, Sasaki T, Maeda K, Murakami M, Kitamura T, Suematsu M, Tsushima Y, Endo K, Hotamisligil GS, Kurabayashi M Iso T PloS ONE 8 e79386
10 2013 Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. Sano K, Nakajima T, Choyke PL, Kobayashi H Kobayashi H ACS Nano 7 717-724
11 2013 Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging. Sano K, Nakajima T, Ali T, Bartlett DW, Wu AM, Kim I, Paik CH, Choyke PL, Kobayashi H Kobayashi H J Biomed Opt 18 101304
12 2013 Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes. Sano K, Nakajima T, Miyazaki K, Ohuchi Y, Ikegami T, Choyke PL, Kobayashi H Kobayashi H Bioconjug Chem 24 811-816
13 2013 Acute cytotoxic effects of photoimmunotherapy assessed by 18F-FDG PET. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H Kobayashi H J Nucl Med 54 770-775
14 2013 Characteristics of cervical computed tomography findings in kawasaki disease: a single-center experience. Katsumata N, Aoki J, Tashiro M, Taketomi-Takahashi A, Tsushima Y Katsumata N J Compu Assist Tomogr 37 681-685
15 2013 The effect of photoimmunotherapy (PIT) followed by liposomal daunorubicin in a mixed tumor model: A demonstration of the super enhanced permeability and retention (SUPR) effect after PIT. Sano K, Nakajima T, Choyke PL, Kobayashi H Kobayashi H Mol Cancer Ther 13 426-432
16 2013 Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. Kaira K., Sunose Y, Ohshima Y., Ishioka S, Arakawa K, Ogawa T, Sunaga N, Shimizu K., Tominaga H, Oriuchi N, Itoh H, Nagamori S, Kanai Y, Yamaguchi A, Segawa A, Ide M, Mori M, Oyama T, Takeyoshi I Kaira K BMC Cancer 13 482
17 2014 Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer. Miyazaki T, Sohda M, Higuchi T, Tanaka N, Suzuki S, Sakai M, Yokobori T, Nakajima M, Fukuchi M, Tsushima Y, Kato H, Kuwano H Miyazaki T Ancicancer Res 34 283-288
18 2014 Peribronchovascular haze: a frequently observed finding on chest X-rays in the acute phase of Kawasaki disease. Moriya S, Aoki J, Tashiro M, Taketomi-Takahashi A, Tsushima Y Moriya S Jpn J Radiol 32 38-43
19 2014 L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer. Sohda M, Honjyo H, Hara K, Ozawa D, Suzuki S, Tanaka N, Sano A, Sakai M, Yokobori T, Inose T, Miyazaki T, Ojima H, Higuchi T, Tsushima Y, Kuwano H Sohda M Ancicancer Res 34 909-913
20 2014 Biological significance of 18F-FDG accumulation on PET in Patients with Non-Small-Cell. Kaira K, Serizawa M, Koh Y, Takahashi T, Yamaguchi A, Hanaoka H, Oriuchi N, Endo M, Ohde Y, Nakajima T, Yamamoto N Kaira K Lung Cancer 83 197-204
21 2014 Fractionated radioimmunotherapy with 90Y-labeled fully human anti-CEA antibody. Hanaoka H, Kuroki M, Yamaguchi A, Achmad A, Iida Y, Higuchi T, Oriuchi N, Endo K Hanaoka H Cancer Biother Radiopharm 29 70-76
22 2014 Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate. Paudyal B, Paudyal P, Shah D, Tominaga H, Tsushima Y, Endo K. Paudyal B J Biomed Sci 21 35
23 2014 Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Nakajima Y, Okamura T, Gohko T, Satoh T, Hashimoto K, Shibusawa N, Ozawa A, Ishii S, Tomaru T, Horiguchi K, Okada S, Takata D, Rokutanda N, Horiguchi J, Tsushima Y, Oyama T, Takeyoshi I, Yamada M. Yamada M Endocr J 61 825-832
24 2014 CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and 11C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer’s disease. Ikeda M, Tashiro Y, Takai E, Kurose S, Fugami N, Tsuda K, Arisaka Y, Kodaira S, Fujita Y, Makioka K, Mizuno Y, Shimada H, Harigaya Y, Takatama M, Amari M, Yamazaki T, Yamaguchi H, Higuchi T, Okamoto K, Tsushima Y, Ikeda Y. Ikeda M Amyloid 20 1-8
25 2014 Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Nakajima Y, Okamura T, Gohko T, Satoh T, Hashimoto K, Shibusawa N, Ozawa A, Ishii S, Tomaru T, Horiguchi K, Okada S, Takata D, Rokutanda N, Horiguchi J, Tsushima Y, Oyama T, Takeyoshi I, Yamada M. Yamada M Endocr J 61 825-832

PAGE TOP